Donor, Recipient and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study
| Autor: | George O D Rosenwasser, Loretta B Szczotka-Flynn, Mark A. Terry, Anthony J. Aldave, Maureen G. Maguire, Elmer Y. Tu, Caroline K. Hoover, Steven P. Dunn, Wendi Liang, Alan Sugar, Sonia H. Yoo, David D. Verdier, Allison R Ayala, Jennifer Rose-Nussbaumer, R. Doyle Stulting, Thomas F. Mauger, Sudeep Pramanik, Yassine J. Daoud, Christopher R. Croasdale, Jonathan H. Lass, Marian S. Macsai |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Adult Male medicine.medical_specialty Time Factors Visual Acuity Cell Count Fuchs' dystrophy Eye Banks Article law.invention Cohort Studies 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Double-Blind Method law Diabetes mellitus Cornea medicine Humans Postoperative Period Aged business.industry Corneal Edema Endothelium Corneal Fuchs' Endothelial Dystrophy Graft Survival Organ Preservation Middle Aged medicine.disease Confidence interval Tissue Donors Transplant Recipients Surgery Endothelial cell density Ophthalmology 030104 developmental biology medicine.anatomical_structure Relative risk Time and Motion Studies 030221 ophthalmology & optometry Female business Descemet Stripping Endothelial Keratoplasty Cohort study |
| Popis: | Purpose To associate donor, recipient, and operative factors with graft success 3 years after Descemet stripping automated endothelial keratoplasty (DSAEK) in the Cornea Preservation Time Study (CPTS). Design Cohort study within a multicenter, double-masked, randomized clinical trial. Participants One thousand ninety individuals (1330 study eyes) with a median age of 70 years undergoing DSAEK for Fuchs endothelial corneal dystrophy (94% of eyes) or pseudophakic or aphakic corneal edema (PACE; 6% of eyes). Methods Eyes undergoing DSAEK were randomized to receive a donor cornea with preservation time (PT) of 0 to 7 days (n = 675) or 8 to 14 days (n = 655). Donor, recipient, and operative parameters were recorded prospectively. Graft failure was defined as regraft for any reason, a graft that failed to clear by 8 weeks after surgery, or an initially clear graft that became and remained cloudy for 90 days. Failure in the first 8 weeks was classified further as primary donor failure or early failure, in the absence or presence of operative complications, respectively. Proportional hazards and logistic regression models were used to estimate risk ratios (RR) and 99% confidence intervals (CIs) for graft failure. Main Outcome Measures Graft success at 3 years. Results One thousand two hundred fifty-one of 1330 grafts (94%) remained clear at 3 years and were considered successful. After adjusting for PT, tissue from donors with diabetes (RR, 2.35; 99% CI, 1.03–5.33) and operative complications (RR, 4.21; 99% CI, 1.42–12.47) were associated with increased risk for primary or early failure. Preoperative diagnosis of PACE (RR, 3.59; 99% CI, 1.05–12.24) was associated with increased risk for late failure by 3 years after surgery compared with Fuchs dystrophy. Graft success showed little variation among other factors evaluated, including donor age (RR, 1.19 per decade; 99% CI, 0.91–1.56 per decade), preoperative donor endothelial cell density (RR, 1.10 per 500 cells; 99% CI, 0.74–1.63 per 500 cells), graft diameter (RR, 1.22 per 1 mm; 99% CI, 0.39–3.76 per 1 mm), and injector use for graft insertion (RR, 0.92; 99% CI, 0.40–2.10). Conclusions Descemet stripping automated endothelial keratoplasty success in the early and entire postoperative period is more likely when the donor did not have diabetes and was without operative complications and in the long-term postoperative period in recipients with Fuchs dystrophy compared with those with PACE. Mechanisms whereby diabetic donors and PACE recipients reduce the rate of graft success after DSAEK warrant further study. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|